New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 12, 2013
06:04 EDTMSFT, PFE, GSK, AAPL, SSNLFOn the Fly: Periodicals Wrap-Up
WALL STREET JOURNAL: With the realization that Microsoft’s (MSFT) new Windows 8 software will not reignite computer sales, attention is shifting to the company's next big effort to regain relevance: Windows Blue, the software project which has yet to formally defined, the Wall Street Journal reports...Of the hundreds of millions of dollars paid each year to compensate physicians for pharmaceutical marketing and research efforts, Pfizer (PFE) and GlaxoSmithKline (GSK) are cutting back. In addition, layoffs of pharmaceutical-sales representatives and patent expirations for big-selling drugs have resulted in fewer sales calls on doctors, the Wall Street Journal reports...REUTERS: World shares declined today as investors locked in profits at the end of what was set to be the second best week of the year for stocks, while the dollar held near a four-year high against the yen, Reuters reports...No fewer than three Wall Street analysts this week wrote reports about the possibility of the biggest banks breaking themselves up to increase profitability, signaling that investors may be more willing to embrace an idea that is still toxic to some lawmakers in Washington, Reuters reports..BLOOMBERG: Apple (AAPL) and Samsung (SSNLF) are being beaten on price in the fast-growing Indian smartphone market by a couple of aggressive local competitors, fueled by Indians buying their first smartphone to surf the Internet, which will be accessed by more than 300M people by 2017, Bloomberg reports...Gold swung between gains and declines as it headed for a third weekly drop in London on speculation a strengthening U.S. economy will curb demand for a protection of wealth. Prices are down 7% this year on rising optimism that the U.S. will help lead a global economic recovery, Bloomberg reports.
News For MSFT;PFE;GSK;AAPL;SSNLF From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | all recent news | >>
October 8, 2014
15:12 EDTAAPLNuance October calls active amid speculation Icahn speculation
Subscribe for More Information
15:00 EDTAAPLApple shares climb following Icahn tweet of open letter to Tim Cook
Activist investor Carl Icahn tweeted that he is sending an open letter to Tim Cook tomorrow. This news along with the better tone in markets has helped lift the shares back above the psychologically important $100 level. Next resistance is at $101.79. Support is at $99.90.
14:54 EDTAAPLApple volatility flat, Icahn says to send open letter to CEO Tim Cook tomorrow
Apple October weekly call option implied volatility is at 23, October is at 20, November is at 26, December is at 24, January is at 23; compared to its 26-week average of 25 according to Track Data, suggesting non-directional price movement on Carl Icahn says to send open letter to CEO Tim Cook tomorrow.
14:36 EDTAAPLIcahn says to send open letter to Apple CEO Tim Cook tomorrow
Subscribe for More Information
12:08 EDTAAPLApple sends out invites for October 16 event, 9to5Mac reports
Apple has sent out invitations for its October 16 event that is expected to introduce new iPads and Macs, 9to5Mac reports. The event will take place at the Town Hall auditorium on its Infinite Loop Campus in Cupertino, California and begin at 1pm ET. Reference Link
11:45 EDTAAPLApple 'surprised' by GT Advanced's Chapter 11 filing, WSJ reports
Apple (AAPL) says it was "surprised" by GT Advanced's (GTAT) Chapter 11 bankruptcy filing on Monday, the Wall Street Journal reports. Apple says it is focused on preserving jobs in Arizona and will continue to work with state and local officials "as we consider our next steps." GT Advanced is a partner for Apple's sapphire initiative. Reference Link
11:41 EDTSSNLF, AAPLJ.C. Penney says store base count 'roughly' where it needs to be
Says evaluating stores to see if EBITDA accretive. Says "disciplined" regarding promotions. Says won't risk margin over promotions. Says Apple (AAPL), Samsung (SSNLF), Amazon (AMZN) taking "chunk" out of consumer spending. Sees returning to 37%-39% gross margins over time.
10:55 EDTPFELeerink pharmaceuticals analyst holds an analyst/industry conference call
Analysts discuss prospects for drugs that raise HDL cholesterol, effects of CETP mechanism, expectations for REVEAL data and the potential place for CETP inhibitors in a crowded hypersholesterolemia landscape on an Analyst/Industry conference call to be held on October 9 at 11 am.
10:44 EDTAAPLFitbit said it has no plans to integrate with iOS 8 Heath app, 9to5Mac says
Subscribe for More Information
09:57 EDTAAPLBlog reveals next-generation Apple iPad Air, 9to5Mac says
Subscribe for More Information
09:38 EDTAAPLActive equity options trading on open
Subscribe for More Information
08:20 EDTAAPLQualcomm opportunity at Xiaomi almost rivals iPhone, says FBR Capital
Subscribe for More Information
08:09 EDTPFEPfizer presents LP2086 Phase 2 study data
Pfizer announced it will present the results of a Phase 2, randomized study to evaluate co-administration of the company’s investigational meningococcal group B vaccine, bivalent recombinant LP2086, or rLP2086, with a licensed quadrivalent human papillomavirus vaccine at IDWeek 2014. Data demonstrated immune responses to both vaccines were generated after concomitant administration of bivalent rLP2086 and HPV4. Prespecified noninferiority criteria were met for the bivalent rLP2086 antigens studied and three of the four antigens for HPV4. Primary immunogenicity endpoints, measured after the third dose, included geometric mean titers against HPV antigens in Groups 1 and 3 and human complement serum bactericidal assay GMTs against meningococcal group B disease test strains in Groups 1 and 2. Secondary immunogenicity endpoints included the rate of seroconversion to HPV antigens. Safety of bivalent rLP2086 was assessed after concomitant administration with HPV4 or saline. The prespecified noninferiority criteria were met for three of four HPV antigens and both meningococcal group B disease test strains. Seroconversion for all four HPV antigens was achieved by 99% or more of the subjects for the groups that received HPV4 concomitantly with bivalent rLP2086 or with saline. More local reactions occurred following administration of bivalent rLP2086 compared with saline but the incidence of these reactions did not increase with subsequent vaccine administration. The rates of local and systemic reactions were comparable when bivalent rLP2086 was given with HPV4 to bivalent rLP2086 given alone.
07:19 EDTPFECBI to hold a conference
Subscribe for More Information
07:18 EDTPFEInfectious Diseases Society of America to hold a conference
ID Week 2014 is being held in Philadelphia on October 8-12.
06:57 EDTAAPLApple's iPhone 6 Plus more popular than iPhone 6, WantChinaTimes says
Subscribe for More Information
06:13 EDTSSNLF, MSFT, AAPLNon-Apple notebook, tablet demand to be weak till 2Q15, DigiTimes reports
Demand for non-Apple (AAPL) notebooks and tablets may remain weak until the second quarter of 2015, reports DigiTimes. Citing Taiwan makers, the pressure due to booming sales from Apple products may decrease sales until Microsoft (MSFT) launches Windows 10 next year. Demand for Samsung (SSNLF), Sony (SNE) , And HTC smartphones have also dropped worldwide recently. Reference Link
06:11 EDTGSKNovartis says expects three executive committee members to leave
Novartis (NVS) confirmed that following completion of the transactions with GlaxoSmithKline (GSK) and Eli Lilly and Company (LLY) in the coming months, that the three business leaders of the Novartis divisions at the center of the transaction will leave the Executive Committee of Novartis. The expected changes to the ECN are subject to the closing of the transactions announced on April 22 - Novartis expects the transaction with GSK to be completed in the first half of 2015, and the transaction with Eli Lilly for its Animal Health Business to close in the first quarter of 2015. George Gunn, currently Division Head, Novartis Animal Health, will reach his contractual retirement age in July 2015 and will retire from Novartis. Upon closing of the Animal Health transaction with Lilly he will leave the ECN. Brian McNamara, currently Division Head, Novartis OTC, will transition to GSK as Head of Americas and Europe for the consumer health businesses, reporting to the President of GSK Consumer Healthcare, effective at closing of the transaction. Andrin Oswald, currently Division Head, Novartis Vaccines, will be leaving Novartis to pursue other opportunities following closing of the transaction with GSK.
06:10 EDTAAPLQuantom begins small-volume production of 12-inch Macbook Air, DigiTimes says
Subscribe for More Information
05:54 EDTAAPLTeen interest in Apple Watch 'tepid,' says Piper Jaffray
Subscribe for More Information
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use